| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 15.090 | 9.026 | 59.330 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 15.178 | 9.041 | 59.460 | 3 | 0 | 0 | 0 | 2.913 | 0 |
| Total Expenses - EUR | 5.223 | 33.792 | 27.794 | 31.617 | 9.602 | 786 | 398 | 72 | 19.394 | 1.070 |
| Gross Profit/Loss - EUR | -5.223 | -18.613 | -18.752 | 27.843 | -9.598 | -786 | -398 | -72 | -16.480 | -1.070 |
| Net Profit/Loss - EUR | -5.223 | -18.917 | -18.843 | 27.250 | -9.598 | -786 | -398 | -72 | -16.480 | -1.070 |
| Employees | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Charolais Genetique Internaţional Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 85 | 16.416 | 11.636 | 35.639 | 29.410 | 20.671 | 19.778 | 20.284 | 1.041 | 768 |
| Inventories | 0 | 7.523 | 7.743 | 341 | 755 | 741 | 725 | 727 | 321 | 0 |
| Receivables | 0 | 6.725 | 2.178 | 20.936 | 20.366 | 19.881 | 19.440 | 19.501 | 720 | 768 |
| Cash | 85 | 2.168 | 1.715 | 14.362 | 8.289 | 48 | -388 | 56 | 0 | 0 |
| Shareholders Funds | -5.178 | -24.042 | -44.350 | -16.286 | -25.569 | -25.870 | -25.695 | -25.846 | -42.339 | -43.173 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.263 | 40.458 | 55.985 | 51.925 | 54.979 | 46.540 | 45.472 | 46.130 | 43.380 | 43.941 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4623 - 4623" | |||||||||
| CAEN Financial Year |
4623
|
|||||||||
Comments - Charolais Genetique Internaţional Srl